Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Dec;25(12):2280-9.
doi: 10.1007/s11695-015-1691-x.

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology

Guy Bower  1 , Tania Toma  1 , Leanne Harling  1 , Long R Jiao  1   2 , Evangelos Efthimiou  1   3 , Ara Darzi  1 , Thanos Athanasiou  1 , Hutan Ashrafian  4   5   6
Affiliations
Meta-Analysis

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology

Guy Bower et al. Obes Surg. 2015 Dec.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is becoming a leading cause of global liver disease that is associated with the rising prevalence of obesity worldwide. There is now increasing clinical and mechanistic evidence reporting on the metabolic and weight loss effects of bariatric surgery on improving NAFLD in obese patients.

Objectives: The aim of this paper was to quantify the effects of bariatric surgery on NAFLD by appraising the modulation between pre- and post-operative liver enzyme levels (as markers of liver injury) and liver histology.

Methods: A systematic review of studies reporting pre-operative and post-operative liver enzymes or liver histology was done in obese patients with NAFLD undergoing bariatric surgery. Data were meta-analysed using random-effects modelling. Subgroup analysis, quality scoring and risk of bias were assessed.

Results: Bariatric surgery is associated with a significant reduction in the weighted incidence of a number of histological features of NAFLD including steatosis (50.2 and 95 %CI of 35.5-65.0), fibrosis (11.9 and 95 %CI of 7.4-16.3 %), hepatocyte ballooning (67.7 and 95 %CI 56.9-78.5) and lobular inflammation (50.7 and 95 %CI 26.6-74.8 %). Surgery is also associated with a reduction in liver enzyme levels, with statistically significant reductions in ALT (11.36 u/l, 95 %CI 8.36-14.39), AST (3.91 u/l, 95 %CI 2.23-5.59), ALP (10.55 u/l, 95 %CI 4.40-16.70) and gamma-GT (18.39 u/l, 95 %CI 12.62-24.16). Heterogeneity in results was high.

Conclusions: Bariatric surgery is associated with a significant improvement in both histological and biochemical markers of NAFLD. Future studies must focus on higher levels of evidence to better identify the benefits of bariatric surgery on liver disease in order to enhance future treatment strategies in the management of NAFLD.

Keywords: Bariatric surgery; Body mass index; Intervention; Metabolic surgery; NAFLD; Non-alcoholic fatty liver disease; Surgery; Weight loss.

PubMed Disclaimer

References

    1. Am J Gastroenterol. 2006 Feb;101(2):368-73 - PubMed
    1. Ann Surg. 2010 Jun;251(6):1041-8 - PubMed
    1. Hepatology. 2008 Apr;47(4):1363-70 - PubMed
    1. J Gastroenterol. 2008;43(1):86-92 - PubMed
    1. Physiol Behav. 2009 Jul 14;97(5):620-31 - PubMed

LinkOut - more resources